Onset of progressive phase is an age-dependent clinical milestone in multiple sclerosis

Creative Commons License

Tutuncu M., Tang J., Abou Zeid N., Kale N., Crusan D. J., Atkinson E. J., ...Daha Fazla

MULTIPLE SCLEROSIS JOURNAL, cilt.19, sa.2, ss.188-198, 2013 (SCI-Expanded, Scopus) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 19 Sayı: 2
  • Basım Tarihi: 2013
  • Doi Numarası: 10.1177/1352458512451510
  • Dergi Adı: MULTIPLE SCLEROSIS JOURNAL
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.188-198
  • Anahtar Kelimeler: Multiple sclerosis, outcome measurement, progressive, relapsing remitting, EDSS, disability, NATURAL-HISTORY, FOLLOW-UP, DIAGNOSTIC-CRITERIA, DISABILITY, MS, DISEASE, IMPAIRMENT, RELAPSE, COHORT, RISK
  • Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
  • İstanbul Üniversitesi-Cerrahpaşa Adresli: Evet

Özet

Background: It is unclear if all patients with relapsing remitting multiple sclerosis (RRMS) ultimately develop progressive MS. Onset of progressive disease course seems to be age- rather than disease duration-dependent. Some forms of progressive MS (e.g. primary progressive MS (PPMS)) are uncommon in population-based studies. Ascertainment of patients with PPMS from clinic-based populations can facilitate a powerful comparison of age at progression onset between secondary progressive MS (SPMS) and PPMS but may introduce unclear biases.